Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

MT-2 Research Peptide: Complete Lab Guide | Palmetto Peptides

The Palmetto Peptides Complete Guide to the Research Peptide MT-2 (Melanotan II) Research Notice: This article covers research on Melanotan II (MT-2) research peptide and PT-141 research peptide — available from Palmetto Peptides for laboratory use only. Resea

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

The Palmetto Peptides Complete Guide to the Research Peptide MT-2 (Melanotan II)

Research Notice: This article covers research on Melanotan II (MT-2) research peptide and PT-141 research peptide — available from Palmetto Peptides for laboratory use only.

Research Use Only Disclaimer: MT-2 (Melanotan II) is sold strictly for in vitro and laboratory research purposes only. It is not approved by the U.S. Food and Drug Administration (FDA) for human or veterinary use. This guide is written for licensed researchers and scientific professionals engaged in in vitro laboratory work. Nothing on this page constitutes medical advice, clinical guidance, or a recommendation for use outside of controlled research settings.

Last Updated: April 19, 2026 | Reading Time: Approximately 19 minutes | Author: Palmetto Peptides Research Team

Quick Answer

MT-2, formally known as Melanotan II, is a synthetic cyclic heptapeptide analog of alpha-melanocyte-stimulating hormone (α-MSH) — a naturally occurring signaling peptide produced in the pituitary gland.

What Is MT-2 Research Peptide?

MT-2, formally known as Melanotan II, is a synthetic cyclic heptapeptide analog of alpha-melanocyte-stimulating hormone (α-MSH) — a naturally occurring signaling peptide produced in the pituitary gland. In laboratory research, MT-2 is classified as a broad-spectrum melanocortin receptor agonist, meaning it binds to and activates multiple receptors within the melanocortin system: specifically MC1R, MC3R, MC4R, and MC5R.

Researchers use MT-2 as a reference compound in receptor pharmacology studies, melanocyte cell culture experiments, structure-activity relationship (SAR) research, and assay development. Its well-characterized binding profile, decades of published characterization data, and commercial availability at research-grade purity have made it one of the most studied synthetic peptides in melanocortin receptor biology.

MT-2 is not approved for any human or veterinary application. All research use is strictly in vitro and laboratory-based.

Quick Reference: MT-2 at a Glance

Full Name

Melanotan II

Abbreviation

MT-2

Type

Synthetic cyclic heptapeptide

Sequence

Ac-Nle-c[Asp-His-D-Phe-Arg-Trp-Lys]-NH₂

Molecular Formula

C₅₀H₆₉N₁₅O₉

Molecular Weight

1024.18 g/mol

CAS Number

121062-08-6

Receptor Targets

MC1R, MC3R, MC4R, MC5R

Research Purity Standard

≥98% by RP-HPLC

Appearance

White to off-white lyophilized powder

Recommended Storage

-20°C, sealed, protected from light

Reconstitution Solvent

0.1% acetic acid in sterile water

Regulatory Status

Research use only; not FDA-approved for human or veterinary use

The Origin of MT-2: A Brief History

MT-2 was developed as part of a systematic melanocortin peptide research program at the University of Arizona, initiated in the late 1970s and producing MT-2's synthesis in the late 1980s and early 1990s. Led by Dr. Victor Hruby and collaborators, the program's original goal was to create synthetic analogs of α-MSH that would be more potent and more metabolically stable than the native hormone — primarily for basic receptor biology research.

The earlier compound Melanotan I (MT-1, or afamelanotide) preceded MT-2 and was a linear analog with selectivity for MC1R. MT-2 followed as a second-generation compound featuring a cyclic backbone, key non-natural amino acid substitutions, and significantly broader receptor activity across the melanocortin family.

Over the 1990s and 2000s, MT-2 became a standard reference compound in the expanding field of melanocortin receptor pharmacology — particularly as research into MC4R and its role in central nervous system signaling grew substantially.

For a detailed timeline of MT-2's scientific development, see our supporting article: History and Development of MT-2 Research Peptide: From Discovery to Modern Laboratory Use.

Chemical Structure of MT-2: Why It Looks the Way It Does

MT-2's structure was deliberately engineered to outperform its parent molecule in laboratory conditions. Understanding a few key features explains why it behaves the way it does in receptor assays.

The Cyclic Backbone

MT-2 contains a lactam bridge — a covalent bond formed between the side chain of Aspartic acid (position 2) and the side chain of Lysine (position 7) in its sequence. This bridge creates a ring structure that locks the peptide into a fixed three-dimensional conformation.

Think of it this way: a linear peptide is like a flexible chain that can wiggle into many different shapes. A cyclic peptide is more like a rigid ring — it presents the same shape to a receptor every time. That consistency reduces the energetic cost of fitting into the receptor's binding pocket, which is a big part of why MT-2 binds melanocortin receptors with substantially higher affinity than native α-MSH.

Key Non-Natural Amino Acid Substitutions

Two deliberate modifications distinguish MT-2 from anything that occurs in biology:

Norleucine (Nle) replacing Methionine: Methionine is oxidation-prone. Norleucine is the structurally similar but oxidation-resistant replacement, preserving the steric properties while eliminating a degradation liability.

D-Phenylalanine (D-Phe) replacing L-Phenylalanine: D-amino acids are mirror images of the naturally occurring L-amino acids. This single inversion causes the peptide backbone to fold in a way that positions MT-2's receptor-binding core — the His-D-Phe-Arg-Trp pharmacophore — in an optimal orientation for melanocortin receptor engagement. This is the primary reason MT-2 is dramatically more potent at receptor binding than native α-MSH.

Terminal Modifications

The N-terminus of MT-2 is capped with an acetyl group and the C-terminus carries an amide group. Both modifications block the peptide's ends from enzymatic cleavage, contributing further to MT-2's stability in aqueous research conditions.

For the full structural breakdown, see: Chemical Structure and Synthesis of Melanotan II (MT-2) Research Peptide Explained.

The Melanocortin System: Context for Understanding MT-2 Research

To understand why MT-2 matters as a research tool, it helps to know what the melanocortin system is and why scientists study it.

Five Receptors, Many Research Areas

The melanocortin system is a family of five G protein-coupled receptors (GPCRs) that respond to melanocortin peptides — a group that includes α-MSH, β-MSH, γ-MSH, and ACTH (adrenocorticotropic hormone). These receptors are found in different tissues and are involved in a variety of physiological signaling pathways studied at the basic science level.

MC1R

Melanocytes, skin

Pigmentation biology, melanogenesis

MC2R

Adrenal cortex

ACTH/cortisol signaling (MT-2 does NOT bind MC2R)

MC3R

Hypothalamus, limbic system

Energy homeostasis signaling

MC4R

Central nervous system (hypothalamus)

Neurological signaling, feeding behavior research

MC5R

Exocrine glands, peripheral tissues

Exocrine and peripheral signaling

MT-2 is a valuable research tool precisely because it activates MC1R, MC3R, MC4R, and MC5R — four of the five receptors in the family — with high affinity. This broad profile makes it useful both as a pan-agonist reference and, in combination with selective antagonists, as a tool for dissecting individual receptor contributions.

How MT-2 Works in Laboratory Studies: The Mechanism of Action

When MT-2 is applied in a cell-based or receptor binding assay, the sequence of molecular events follows a well-characterized pathway:

Step 1: Receptor Binding

MT-2 occupies the orthosteric binding site on melanocortin receptors. The pharmacophore sequence — His-D-Phe-Arg-Trp — makes the key contacts with the receptor's binding pocket. The cyclic conformation presents these contacts in a pre-organized geometry that improves binding affinity relative to linear analogs.

Step 2: G Protein Activation

Melanocortin receptors (MC1R, MC3R, MC4R, MC5R) couple primarily to Gs proteins — stimulatory G proteins. When MT-2 occupies the receptor, it drives a conformational change that activates the associated Gs alpha subunit.

Step 3: cAMP Elevation (The Primary Measurable Signal)

The activated Gs alpha subunit stimulates adenylyl cyclase, which converts ATP to cyclic AMP (cAMP) — the primary intracellular second messenger of the melanocortin signaling cascade. In virtually every cell-based MT-2 study, intracellular cAMP elevation is the key downstream readout.

Step 4: PKA Activation and Cell-Type-Specific Downstream Effects

Elevated cAMP activates Protein Kinase A (PKA), which phosphorylates targets that vary by cell type. In melanocytes, this leads ultimately to MITF transcription factor upregulation and activation of melanin synthesis genes. In neurons expressing MC4R, it affects ion channel activity and neuropeptide signaling networks. The specific downstream effects depend on which receptor is activated and in which cellular context.

For a complete mechanistic breakdown, see: Mechanism of Action of MT-2 Research Peptide in Melanocortin Receptor Studies.

MT-2 vs Melanotan I: Key Differences for Researchers

Melanotan I (MT-1) and MT-2 are both synthetic melanocortin agonists derived from the same research program, but they are meaningfully different compounds. Choosing the wrong one for your experiment can introduce significant receptor-selectivity confounds.

The Short Version

MT-1 is a longer, linear peptide with strong selectivity for MC1R. Researchers who want clean MC1R pharmacology in a melanocyte cell line often prefer MT-1 because its activity is more confined to that single subtype.

MT-2 is shorter, cyclic, and activates MC1R, MC3R, MC4R, and MC5R with comparable high affinity. Researchers studying MC4R, conducting pan-melanocortin activation studies, or using MT-2 as a reference compound in SAR work choose MT-2 for its broader profile and its much larger published literature base.

Length

13 amino acids (linear)

7 amino acids (cyclic)

Receptor selectivity

MC1R preferred

Best for

Isolated MC1R studies

MC4R, pan-agonist, SAR reference

Stability in solution

Moderate

High (cyclic backbone)

For the full comparison, see: MT-2 vs Melanotan I Research Peptides: Key Differences for Laboratory Applications.

Current Research Applications of MT-2

MT-2 serves several distinct functions in the scientific literature. Here is a summary of where it is actively used:

Melanocyte and Pigmentation Biology Research

In melanocyte cell lines such as B16-F10 (mouse) and SK-MEL-28 (human), MT-2 is used to study MC1R signaling, cAMP responses, MITF regulation, and tyrosinase-driven melanin synthesis. These are some of the most well-established in vitro applications in the MT-2 literature.

MC4R and CNS-Related Cell Studies

MC4R is among the most studied GPCRs in neuroscience. In hypothalamic cell lines (GT1-7) and HEK293 cells stably expressing MC4R, MT-2 is used to characterize receptor activity, downstream signaling effectors, and the effects of novel MC4R ligands relative to this reference agonist.

Structure-Activity Relationship (SAR) Research

Medicinal chemists studying new melanocortin ligands use MT-2 as the reference compound against which novel analogs are compared. MT-2's thoroughly documented binding profile across four receptor subtypes makes it the natural baseline for selectivity optimization studies.

Assay Development and Validation

MT-2 is the positive control of choice in melanocortin receptor functional assays. When researchers develop or validate a new cAMP assay system, MT-2's known EC50 is used to benchmark assay performance before the system is used on test compounds.

For the full picture of research applications, see: Current Research Applications of MT-2 Peptide in Scientific Cell and Receptor Studies.

MT-2 Purity and Quality: What Researchers Need to Know

The quality of your MT-2 research peptide directly affects the reliability of your data. A lower-purity peptide introduces unknown compounds — synthesis impurities, deletion sequences, oxidized variants — that can interact with your receptors or cell systems in ways you cannot control or account for.

Minimum Purity Standard: 98% by RP-HPLC

Research-grade MT-2 should be at minimum ≥98% pure as determined by reverse-phase HPLC (RP-HPLC). This is the industry standard for peptides used in receptor pharmacology. Some suppliers advertise 95% as "research grade" — it is not adequate for receptor binding assays or cell-based work where impurities can confound results.

Identity Confirmation: Mass Spectrometry

HPLC tells you purity. Mass spectrometry tells you identity. Every legitimate MT-2 supplier should provide lot-specific MS data confirming the observed molecular mass is consistent with MT-2's theoretical weight of 1024.18 g/mol.

Certificate of Analysis: What to Require

Before purchasing MT-2 from any supplier, researchers should confirm that a lot-specific Certificate of Analysis (CoA) is available. The CoA should include an HPLC chromatogram (not just a purity number), MS identity data, the lot number matching the vial, and storage recommendations.

What a Quality CoA Looks Like

HPLC purity

≥98% with chromatogram

Number only, no trace

MS data

Matches 1024.18 Da

Missing or doesn't match

Lot number

Specific to the vial

Generic or undated

Endotoxin

EU/mg value provided

Not tested

Storage

-20°C lyophilized

Not specified

For a full guide to evaluating supplier quality, see: Purity Testing and Quality Control Methods for MT-2 Research Peptides. And for guidance on what to look for when purchasing, see: Buyer's Guide: What to Consider When Purchasing MT-2 Research Peptide Online.

Storing MT-2 Research Peptide: The Essentials

Improper storage is one of the most common reasons researchers get inconsistent results from peptide experiments. MT-2 is not uniquely fragile, but it does degrade through predictable pathways — all of which are manageable with correct protocols.

Lyophilized MT-2 Storage

Store sealed vials at -20°C or lower, protected from light and moisture. Under these conditions, properly stored lyophilized MT-2 maintains stability for 24–36 months. For archive storage beyond 18 months, -80°C is preferable.

One rule that many researchers skip: allow the sealed vial to equilibrate to room temperature before opening. Opening a cold vial in a warm, humid lab environment allows condensation to enter and absorb into the lyophilized powder — introducing the moisture that drives hydrolytic degradation before reconstitution even begins.

Reconstituted MT-2 Storage

Once dissolved, MT-2 solution is more vulnerable than the lyophilized powder. Best practices:

Store at 4°C for short-term use (up to 4 weeks)

Store at -20°C for longer periods (up to 3 months)

Aliquot into single-use volumes before first freeze — repeated freeze-thaw cycles degrade peptide activity incrementally

Use low-bind (LoBind) microcentrifuge tubes — standard plastic adsorbs peptide at nanomolar concentrations

Protect from light at all stages

For the full storage protocol, see: Best Practices for Storing MT-2 Research Peptide to Preserve Potency in the Lab.

How to Reconstitute MT-2 Research Peptide

Reconstitution is the process of dissolving lyophilized MT-2 in solvent to create a working stock solution. It takes less than 15 minutes but has a few non-obvious details that matter for data quality.

Recommended Solvent: 0.1% Acetic Acid

The most widely used and best-supported solvent for MT-2 reconstitution is 0.1% acetic acid in sterile water. The slightly acidic pH slows hydrolysis and promotes peptide solubility better than neutral water or PBS.

To prepare: add 1 µL of glacial acetic acid per 1 mL of sterile water. Alternatively, purchase pre-made sterile 0.1% acetic acid from a lab supply vendor.

Concentration Calculation Shortcut

MT-2 molecular weight: 1024.18 g/mol

To make a 1 mg/mL stock (approximately 1 mM):

Add 1 mL of solvent per 1 mg of peptide

For a 5 mg vial: add 5 mL of solvent

Reconstitution Protocol (Condensed)

Allow sealed vial to reach room temperature (10–15 minutes, sealed)

Inspect lyophilized powder (white to off-white, consistent appearance)

Add calculated solvent volume slowly against the vial wall

Gently swirl or roll until dissolved — do not vortex vigorously

Solution should be clear and colorless

Filter through 0.22 µm if using in cell culture applications

Divide into single-use aliquots in labeled low-bind tubes

Store at 4°C (short-term) or -20°C (long-term)

For the complete step-by-step protocol, see: Step-by-Step Reconstitution of MT-2 Research Peptide for Laboratory Experiments.

Reconstituted MT-2 Stability and Shelf Life

Once reconstituted, MT-2's usable life depends on storage conditions and how many times the solution has been frozen and thawed.

Stability by Condition

4°C in 0.1% acetic acid

2–4 weeks

-20°C, single-use aliquots

Up to 3 months

-80°C, single-use aliquots

Up to 6+ months

nM working solution (any condition)

Prepare fresh before each run

Key Stability Rules

Maximum 3 freeze-thaw cycles per aliquot before replacing

Yellow or brown discoloration signals oxidation of Trp or His residues — do not use

Cloudiness or visible particulate indicates aggregation — do not use

At nanomolar concentrations, prepare working solutions fresh before each assay from a frozen stock

For detailed stability data and monitoring guidance, see: Long-Term Stability of Reconstituted MT-2 Research Peptide Solutions for Lab Protocols.

Purchasing MT-2 Research Peptide: What to Look For

The research peptide market varies widely in quality. Researchers who rely on poorly documented or low-purity MT-2 introduce experimental variables that undermine reproducibility — and that can take significant time to diagnose.

Non-Negotiable Standards When Buying MT-2

Lot-specific CoA with HPLC chromatogram included

≥98% purity by RP-HPLC

Mass spectrometry identity confirmation

Research-use-only labeling on all products and marketing

Cold chain shipping to maintain lyophilized peptide integrity

Red Flags

Generic CoA not matched to your lot

Purity listed without supporting chromatogram

No mass spectrometry data

No verifiable business address or contact

Unusually low pricing (which often reflects compromised purity or testing shortcuts)

See the full purchasing guide: Buyer's Guide: What to Consider When Purchasing MT-2 Research Peptide Online.

Why Researchers Choose Palmetto Peptides for MT-2

At Palmetto Peptides, every MT-2 research peptide we supply meets the following standards:

≥98% purity by RP-HPLC (many lots achieve ≥99%), confirmed by lot-specific chromatogram

Mass spectrometry identity verification on every lot

Lot-specific Certificate of Analysis with full analytical data available with every order

Research-use-only labeling and FDA compliance disclaimers on all products

Cold chain shipping to protect lyophilized integrity during transit

We sell exclusively to researchers for in vitro laboratory applications. MT-2 and all Palmetto Peptides products are not sold for human or veterinary use under any circumstances.

Explore our MT-2 Research Peptide product page to view current lot availability and request documentation.

Looking for

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Research context

Read sources and limitations before applying a claim.

In Vitro Models for MC4R Research

GT1-7 cells: A murine hypothalamic neuronal cell line that expresses functional MC4R. Commonly used for cAMP signaling studies and downstream receptor effector characterization. HEK293 cells transfected with MC4R: Human embryonic kidney cells stably or transiently expressing recombinant MC4R are widely used because they provide a clean background (minimal endogenous melanocortin receptor expression) against which MC4R pharmacology can be studied in isolation. Primary hypothalamic neurons: More physiologically relevant but technically demanding. MT-2's stability and potency make it suitable for these systems where degradation of a less stable agonist would reduce signal consistency.

Source: palmettopeptides.com ↗

GABAergic Mechanisms: Updated Research Through 2026

One of the most active areas of Selank research going into 2025-2026 involves refining exactly how the peptide interacts with GABAergic neurotransmission. Earlier models proposed a relatively simple inhibition of GABA reuptake transporters, but more recent preclinical work using electrophysiological recording and targeted pharmacological antagonism has produced a more nuanced picture. Updated research in rodent cortical and hippocampal slice preparations suggests that Selank's GABAergic effects may involve modulation of GABA-A receptor subunit composition over time — specifically, a shift toward subunit configurations associated with tonic inhibition rather than phasic synaptic transmission. This distinction matters mechanistically because tonic GABAergic inhibition is closely linked to the regulation of anxious arousal states, and its modulation may explain why Selank produces anxiolytic behavioral effects without the pronounced sedation seen with compounds that act primarily on phasic synaptic GABA-A receptors. Emerging 2025 data also revisited the role of enkephalinase (neutral endopeptidase) inhibition in Selank's mechanism. This enzyme degrades a range of endogenous neuropeptides including enkephalins and several BDNF-related fragments. Research in rat models suggests that the degree of enkephalinase inhibition produced by Selank may vary substantially depending on route of administration and tissue compartment, adding an important caveat to earlier models that treated this mechanism as a primary driver of the peptide's effects.

Source: palmettopeptides.com ↗
Practical and safety references

These excerpts are educational, not personalised medical instructions.

Dosage reference

Dosing Frequency

With a ~7-day half-life in rodent models, once-weekly subcutaneous administration achieves gradual accumulation toward steady state. Some published protocols have used every-other-day dosing in mice to accelerate initial accumulation in shorter studies. The appropriate dosing frequency depends on the research objective and should be referenced directly from the published protocol being replicated or adapted.

Source: palmettopeptides.com ↗
Storage reference

Dedicated Storage Location

Store peptide research vials in a designated area of the laboratory refrigerator, away from food, biological samples, or other potential contamination sources. A sealed container, such as a clean zipper storage bag or a purpose-made refrigerator organizer, helps maintain separation.

Source: palmettopeptides.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →